**Core Concept**
Methicillin-resistant Staphylococcus aureus (MRSA) poses a challenge in terms of antibiotic resistance, making it essential to select effective antimicrobial agents. The primary concern is to choose antibiotics that are not affected by the mecA gene, which confers resistance to beta-lactam antibiotics.

**Why the Correct Answer is Right**
MRSA is resistant to beta-lactam antibiotics due to the mecA gene, which encodes for an altered penicillin-binding protein (PBP2a). This protein has a low affinity for beta-lactam antibiotics, rendering them ineffective. Therefore, antibiotics that are not beta-lactams or have a different mechanism of action can be effective against MRSA. Vancomycin is a glycopeptide antibiotic that inhibits cell wall synthesis by binding to the D-alanyl-D-alanine terminus of cell wall precursors, making it effective against MRSA. Daptomycin is a cyclic lipopeptide antibiotic that disrupts the bacterial membrane, leading to cell death. Linezolid is an oxazolidinone antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because clindamycin is a lincosamide antibiotic that can be effective against MRSA, but it is not the best choice due to the risk of resistance development and Clostridioides difficile-associated diarrhea.

**Option B:** This option is incorrect because doxycycline is a tetracycline antibiotic that can be effective against some strains of MRSA, but it is not the best choice due to concerns about resistance and potential side effects.

**Option C:** This option is incorrect because sulfamethoxazole/trimethoprim is a combination antibiotic that can be effective against some strains of MRSA, but it is not the best choice due to concerns about resistance and potential side effects.

**Clinical Pearl / High-Yield Fact**
When treating MRSA infections, it is essential to consider the local resistance patterns and the potential for cross-reactivity between antibiotics. Always consult the latest antibiotic resistance surveillance reports and consider consulting an infectious disease specialist for guidance.

**Correct Answer: A. Clindamycin**